Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01050075 · ClinicalTrials.gov registry record · NA
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A NA study, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01050075: Clinical Trial NA study, sponsored by City of Hope Medical Center.
NCT01050075 is a NA study that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01050075, a NA study, was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
RATIONALE: Acupuncture may help relieve nerve pain caused by chemotherapy. PURPOSE: This randomized clinical trial is studying how well acupuncture works in treating nerve pain in patients with stage I, stage II, and stage III breast cancer who are receiving paclitaxel.
Interventions
- OTHER questionnaire administration
- OTHER management of therapy complications
- OTHER acupuncture therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-05 |
| Phase | NA |
Why NCT01050075 stopped before completion
NCT01050075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01050075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01050075 about?
NCT01050075 is a clinical study titled "Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel". RATIONALE: Acupuncture may help relieve nerve pain caused by chemotherapy. PURPOSE: This randomized clinical trial is studying how well acupuncture works in treating nerve pain in patients with stage I, stage II, and stage III breast cancer who are receiving paclitaxel.
What is the current status of trial NCT01050075?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2010-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01050075?
The interventions under investigation include: questionnaire administration (OTHER), management of therapy complications (OTHER), acupuncture therapy (OTHER).
Who is sponsoring clinical trial NCT01050075?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01050075's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia